SEC Form 4 · accession 0000914190-15-000020
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Martin
Officer — President and CEO · Director
Period of report
Feb 6, 2015
Accepted (ET)
Feb 10, 2015 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 6, 2015 | S | 1,000 | $35.70 | D | 379,189 | D | |
| Common StockF2 | Feb 9, 2015 | S | 2,000 | $35.65 | D | 377,189 | D | |
| Common Stock | Feb 10, 2015 | S | 1,000 | $36.24 | D | 376,189 | D | |
| Common Stock | Feb 10, 2015 | S | 3,500 | $35.90 | D | 372,689 | D | |
| Common Stock | holding | — | — | — | 850 | I | By child | |
| Common Stock | holding | — | — | — | 350 | I | By child | |
| Common Stock | holding | — | — | — | 850 | I | By child |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $8.83 | holding | — | — | — | — | Feb 14, 2017 | Common Stock | 20,800 | 20,800 | D |
| Stock Option (right to buy)F3 | $7.90 | holding | — | — | — | — | Jun 11, 2017 | Common Stock | 90,580 | 90,580 | D |
| Stock Option (right to buy)F3 | $12.15 | holding | — | — | — | — | Dec 11, 2017 | Common Stock | 234,395 | 234,395 | D |
| Stock Option (right to buy)F3 | $8.75 | holding | — | — | — | — | Mar 1, 2019 | Common Stock | 32,350 | 32,350 | D |
Explanation of responses
- F1Sale of shares to provide funds to satisfy certain tax obligations of the reporting person.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.55 to $35.75 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3Fully exercisable.